Journey Medical Corporation (DERM) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
9237 East Via de Ventura Boulevard
Scottsdale, AZ 85258
United States of America (the)
Phone
480 434 6670
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
41
First IPO Date
November 12, 2021
| Name | Title | Pay | Year Born |
| Claude Maraoui | Founder, President, Chief Executive Officer & Director | 950,230 | 1967 |
| Lindsay Allan Rosenwald | Executive Chairman | 50,000 | 1955 |
| Joseph Benesch | Chief Financial Officer & Corporate Controller | 436,951 | 1967 |
| Ramsey Alloush | Chief Operating Officer, General Counsel & Company Secretary | 591,984 | 1986 |
| Jaclyn Jaffe | Senior Director of Corporate Operations | 0 | N/A |
| Louis Donati | Director of Market Access | 0 | N/A |
| Robert Nevin | Chief Commercial Officer | 0 | 1969 |
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.